Hyoscine-N-Butyl Bromide Market Is Expected To Register 4.6% CAGR By 2027

Chemical & Materials

According to the latest study by Fact.MR, the Hyoscine-N-Butyl Bromide market is expected to bring in more than US$ 50 million in 2019. The study opines that growing prevalence of irritable bowel syndrome (IBS) will continue to underpin hyoscine-N-butyl bromide sales. Over the past few years, the prevalence of IBS and abdominal pain as the gastrointestinal tract disorder has increased, resulting in the increasing consumption of anti-spasmodic drugs. IBS has emerged as one of the most common causes of abdominal pain in the last few years, according to the International Foundation for Gastrointestinal Disorders, the prevalence of IBS is estimated around 10-15% globally.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=3269

Hyoscine-N-Butyl Bromide Market: Research Methodology

The report on the Hyoscine-N-Butyl Bromide market provides valuable and actionable insights and in-depth analysis backed by the robust research methodology. The insights on the Hyoscine-N-Butyl Bromide market are offered through extensive primary and secondary research.

Exclusive interviews and discussions with industry experts were conducted as the part of primary research. Meanwhile, press releases, journals, annual reports of the companies in the Hyoscine-N-Butyl Bromide market and other valid data sources were used to obtain information and data on the Hyoscine-N-Butyl Bromide market.

The conclusions in the report were drawn by combining both the research methodologies, by eliminating the misleading information and providing accurate information on the Hyoscine-N-Butyl Bromide market. 2018 has been considered as the base year to offer forecast on the Hyoscine-N-Butyl Bromide market for the period from 2019 to 2027.

The report on the Hyoscine-N-Butyl Bromide market serves as an authentic dataset for readers and players to plan business strategies in order to stay competitive in the Hyoscine-N-Butyl Bromide market.

Hyoscine-N-Butyl Bromide Market: Segmentation

  • Application

    • Oral
    • Injectables
  • Regions

    • North America
    • Latin America
    • Europe
    • Japan
    • Asia Pacific (Excluding Japan)
    • Middle East & Africa

Europe to Remain Most Lucrative for Hyoscine N-Butyl Bromide Market

According to the report, Europe is likely to remain the most lucrative region in the hyoscine N-butyl bromide market, owing to the significant growth in the geriatric population in the region that is more prone to abdominal pain and chronic gastrointestinal diseases. In Europe, hyoscine-N-butyl bromide with brand name as buscopan is finding widespread application in the radiology as anti-spasmodic agent. It is also used to freeze the bowel motion as part of MRI and CT studies.

In the past few years, abdominal pain has gained significance as one of the early signs of meningococcal infection in Europe. This form of infection is becoming increasingly common in Europe, with abdominal pain as one of the key symptoms. According to the latest research study, 10% of patients infected with the meningococcal strain in Europe suffer from stomach pain.

Leave a Reply

Related Posts